RESMED INC
Company Stats
- Market Cap
- $31.9B
- as of Sep 30, 2026
- Enterprise Value
- $31.1B
- Shares Outstanding
- 144.3M
- Free Float
- 95.0%
Income Statement
- Revenue
- $5.7B
- Operating Income
- $1.9B
- Net Income
- $1.5B
- EBITDA
- $2.1B
- Revenue Growth, 3Y
- 10.2%
- FCF Margin, 3Y Avg
- 29.8%
- FCF Margin, Worst Year
- 27.8%
Cash Flow
- Free Cash Flow
- $1.6B
- FCF Yield
- 5.2%
- Owner FCF Yield
- 4.8%
Balance Sheet
- Cash & Equivalents
- $1.5B
- Total Debt
- $659.4M
- Net Cash
- $809.9M
- EV / EBITDA
- 14.89x
Returns & Capital
- Dividends Paid
- $349.7M
- Dividend Yield
- 1.1%
- Dividend Payout, 3Y Avg
- 24.3%
- Share Repurchases
- $700.0M
- Buyback Yield, 3Y Avg
- 1.2%
- SBC, 3Y Avg
- $92.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2026 | $5.7B | $1.6B | 29.2% |
| FY2025 | $5.1B | $1.7B | 32.3% |
| FY2024 | $4.7B | $1.3B | 27.8% |
| FY2023 | $4.2B | $573.6M | 13.6% |
| FY2022 | $3.6B | $216.3M | 6.0% |
Annual filing data through FY ended June 30, 2026; shares and float as of October 9, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back